Literature DB >> 7356566

Mechanism of interference by hemoglobin in the determination of total bilirubin. I. Method of Malloy-Evelyn.

B C Shull, H Lees, P K Li.   

Abstract

Oxyhemoglobin is the species of hemoglobin in erythrocyte hemolysates that inhibits the diazo reaction. Ferric hemoglobin derivatives and species with relatively low molecular mass do not interfere. Conversion of oxyhemoglobin to acid hematin under assay reaction conditions is associated with rapid destruction of bilirubin, which accounts for the diazo reaction error. The most probable mechanism for this destruction of bilirubin is an oxidative reaction involving H2O2, formed in the oxidation of hemoglobin, and acid hematin acting as a pseudoperoxidase. We could find no evidence for other mechanisms of interference such as spectral error or azobilirubin destruction. Addition of potassium iodide, 4.0 mmol/L final concentration in the reaction mixture, eliminates interference from hemoglobin added to give concentrations as great as 10 g/L. It also eliminated the effects of hemolysis in the method of Ertingshausen et al. (Clin. Chem. 19: 1366, 1973), in which ethylene glycol is used as the accelerator.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7356566

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  3 in total

1.  Prognostic value of direct bilirubin in neonatal hyperbilirubinemia.

Authors:  Manju Mamtani; Archana Patel; Ramesh Renge; Hemant Kulkarni
Journal:  Indian J Pediatr       Date:  2007-09       Impact factor: 1.967

2.  ACVIM consensus statement on the diagnosis of immune-mediated hemolytic anemia in dogs and cats.

Authors:  Oliver A Garden; Linda Kidd; Angela M Mexas; Yu-Mei Chang; Unity Jeffery; Shauna L Blois; Jonathan E Fogle; Amy L MacNeill; George Lubas; Adam Birkenheuer; Simona Buoncompagni; Julien R S Dandrieux; Antonio Di Loria; Claire L Fellman; Barbara Glanemann; Robert Goggs; Jennifer L Granick; Dana N LeVine; Claire R Sharp; Saralyn Smith-Carr; James W Swann; Balazs Szladovits
Journal:  J Vet Intern Med       Date:  2019-02-26       Impact factor: 3.333

3.  Optimization of hemolysis, icterus and lipemia interference thresholds for 35 clinical chemistry assays.

Authors:  Clement K M Ho; Claire Chen; Johnson W S Setoh; Willie W T Yap; Robert C W Hawkins
Journal:  Pract Lab Med       Date:  2021-04-27
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.